Procter & Gamble Health Ltd.

View in App
4968.15 +107.20 ▲2.2%

25 September 2023, 04:01:00 PM
Volume: 371

Company Profile

View details >>
Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.pghealthindia.com
Market Cap 8,244.17 Cr.
Enterprise Value(EV) 7,803.95 Cr. 2023-06
Financial Indicators
Earnings per share (EPS) 138.24 Trailing Twelve Months Ending 2023-06
Price-Earning Ratio (PE) 35.93 Trailing Twelve Months Ending 2023-06
Industry PE 37.43 Trailing Twelve Months Ending 2023-06
Book Value / Share 452.36 Trailing Twelve Months Ending 2023-06
Price to Book Value 10.98 Calculated using Price: 4,966.55
Dividend Yield 1.91 Period Ending 2022-06
No. of Shares Subscribed 1.66 Cr. 16,599,382 Shares
FaceValue 10
About Procter & Gamble Health Ltd.
Till 2018, the Company was operating in all businesses included in the pharmaceuticals and chemicals businesses in the country. The company is one of India's largest VMS Companies manufacturing and marketing over-the-counter products, vitamins, minerals, and supplements products for a healthy lifestyle and improved quality of life. Its trusted products are household names in India protecting and supporting millions of people at every stage of life.

Procter & Gamble Health Ltd. Delivery

View details >>
Delivered Qty
Traded Qty

Procter & Gamble Health Ltd. Performance

View details >>
1 Day
+2.21%
1 Week
+0.77%
1 Month
-7.31%
3 Month
-3.28%
6 Month
+0.57%
1 Year
+21.18%
2 Year
-7.54%
5 Year
+66.05%
10 Year
+785.83%

Procter & Gamble Health Ltd. Fundamental Ratios

View details >>
9 years 2013-12 2014-12 2015-12 2016-12 2017-12 2018-12 2020-06 2021-06 2022-06
Return on Equity (%) 11.10 8.02 9.35 12.61 8.74 8.95 20.79 22.04 29.41
Return on Capital Employed (%) 17.53 12.36 14.54 18.35 14.16 13.90 29.01 29.08 38.45
Return on Assets (%) 6.25 4.37 3.92 5.48 4.24 4.96 10.82 8.65 9.82

Procter & Gamble Health Ltd. Balance Sheet

View details >>
Particulars 10 years 2013-12 Rs. Cr. 2014-12 Rs. Cr. 2015-12 Rs. Cr. 2016-12 Rs. Cr. 2017-12 Rs. Cr. 2018-12 Rs. Cr. 2020-06 Rs. Cr. 2021-06 Rs. Cr. 2022-06 Rs. Cr. 2023-06* Rs. Cr.
Shh. Funds 523 554 592 664 733 1,540 906 704 616 751
Non Curr. Liab. 13 390 395 399 431 495 667 723 715 21
Curr. Liab. 237 260 539 301 352 548 539 551 612 304
Minority Int.
Equity & Liab. 773 1,204 1,525 1,363 1,516 2,583 2,112 1,978 1,943 1,076
Non Curr. Assets 171 581 579 613 637 693 847 939 954 280
Curr. Assets 602 623 946 750 879 1,889 1,265 1,039 989 796
Misc. Exp. not W/O
Total Assets 773 1,204 1,525 1,363 1,516 2,583 2,112 1,978 1,943 1,076

Procter & Gamble Health Ltd. Profit and Loss

View details >>
Particulars 10 years 2013-12 Rs. Cr. 2014-12 Rs. Cr. 2015-12 Rs. Cr. 2016-12 Rs. Cr. 2017-12 Rs. Cr. 2018-12 Rs. Cr. 2020-06 Rs. Cr. 2021-06 Rs. Cr. 2022-06 Rs. Cr. 2023-06 Rs. Cr. TTM
Net Sales 798 867 940 993 698 849 1,356 1,009 1,114 1,230
Other Income 21 20 23 24 30 28 70 18 13 18
Total Income 819 888 963 1,017 729 877 1,426 1,027 1,128 1,248
Total Expenditure -721 -809 -856 -877 -628 -705 -1,042 -763 -847 -903
PBIDT 98 79 107 140 101 173 384 264 281 345
Interest -1 0 -1
Depreciation -10 -13 -23 -25 -19 -21 -29 -30 -27 -30
Taxation -32 -23 -30 -36 -38 -56 -101 -56 -61 -85
Exceptional Items 17 7
PAT 56 43 54 79 61 102 254 177 193 229
Adjusted EPS 34 26 32 48 37 61 153 107 116 138

Procter & Gamble Health Ltd. Cash Flow

View details >>
Particulars 10 years 2012-12 Rs. Cr. 2013-12 Rs. Cr. 2014-12 Rs. Cr. 2015-12 Rs. Cr. 2016-12 Rs. Cr. 2017-12 Rs. Cr. 2018-12 Rs. Cr. 2020-06 Rs. Cr. 2021-06 Rs. Cr. 2022-06 Rs. Cr.
Cash Fr. Operatn. 54 0 5 83 107 54 -130 235 247 170
Cash Fr. Inv. -82 7 11 -68 -75 -48 1,270 165 -32 -26
Cash Fr. Finan. -5 -17 -12 -15 -22 -30 -883 -387 -289
Net Change -28 3 -1 4 17 -16 1,109 -483 -172 -145
Cash & Cash Eqvt 4 7 5 9 26 10 1,119 636 464 319

Procter & Gamble Health Ltd. Shareholding Pattern

View details >>
9 Qtrs 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%)
Promoter 51.82 51.82 51.82 51.82 51.82 51.85 51.82 51.82 51.82
Public 48.18 48.18 48.18 48.18 48.18 48.15 48.18 48.18 48.18
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Procter & Gamble Health Ltd. Announcements

View details >>
Fri, 22 Sep 2023
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Find enclosed details with respect to loss of share certificates(s) received from shareholder(s) of the Company.
Fri, 08 Sep 2023
Communication In Respect Of Deduction Of Tax At Source (TDS) On The Amount Of Dividend Income From Procter & Gamble Health Limited ('The Company')
Find enclosed details with respect to tax deduction at source on dividend income declared by the Company
Wed, 30 Aug 2023
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Find details of duplicate share certificates issued to shareholders of the Company

Procter & Gamble Health Ltd. Technical Scans

View details >>
Mon, 25 Sep 2023
Close Crossing Last Month Close From Below Close Crossing Last Month Close From Below
Closing Above Previous High Closing Above Previous High
Close Within 52 Week High Zone Close Within 52 Week High Zone
Closing Near 20 SMA Closing Near 20 SMA
Close Crossing 20 SMA From Below Close Crossing 20 SMA From Below

Procter & Gamble Health Ltd. Related Stocks

View details >>
  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 269,697.25 1,124.05 -0.7%
Divi's Laboratories Ltd. 99,021.11 3,730.05 +0.6%
Cipla Ltd. 95,166.58 1,180.05 -0.6%
Dr. Reddy's Laboratories Ltd. 90,720.90 5,439.40 -1.4%
Apollo Hospitals Enterprise Ltd. 73,268.35 5,095.45 +2.2%
Mankind Pharma Ltd. 69,694.38 1,739.80 -0.7%
Torrent Pharmaceuticals Ltd. 62,519.33 1,844.85 -0.3%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-06 31.97 1,124.05 -0.7%
Divi's Laboratories Ltd. Consolidated 2023-06 67.03 3,730.05 +0.6%
Cipla Ltd. Consolidated 2023-06 30.62 1,180.05 -0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-06 19.21 5,439.40 -1.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-06 109.58 5,095.45 +2.2%
Mankind Pharma Ltd. Consolidated 2023-03 54.37 1,739.80 -0.7%
Torrent Pharmaceuticals Ltd. Consolidated 2023-06 49.55 1,844.85 -0.3%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-06 4.65 1,124.05 -0.7%
Divi's Laboratories Ltd. Consolidated 2023-06 7.55 3,730.05 +0.6%
Cipla Ltd. Consolidated 2023-06 3.91 1,180.05 -0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-06 3.70 5,439.40 -1.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-06 11.68 5,095.45 +2.2%
Mankind Pharma Ltd. Consolidated 2023-03 5.69 1,739.80 -0.7%
Torrent Pharmaceuticals Ltd. Consolidated 2023-06 9.49 1,844.85 -0.3%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,124.05 -0.7%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,730.05 +0.6%
Cipla Ltd. Consolidated 2023-03 0.02 1,180.05 -0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 5,439.40 -1.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 0.44 5,095.45 +2.2%
Mankind Pharma Ltd. Consolidated 2023-03 0.02 1,739.80 -0.7%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 0.85 1,844.85 -0.3%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,124.05 -0.7%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,730.05 +0.6%
Cipla Ltd. Consolidated 2023-03 12.85 1,180.05 -0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,439.40 -1.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 5,095.45 +2.2%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 1,739.80 -0.7%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 1,844.85 -0.3%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,124.05 -0.7%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,730.05 +0.6%
Cipla Ltd. Consolidated 2023-03 12.85 1,180.05 -0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,439.40 -1.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 5,095.45 +2.2%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 1,739.80 -0.7%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 1,844.85 -0.3%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,124.05 -0.7%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,730.05 +0.6%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,180.05 -0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 5,439.40 -1.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 16,612.50 5,095.45 +2.2%
Mankind Pharma Ltd. Consolidated 2023-03 8,749.43 1,739.80 -0.7%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9,620.15 1,844.85 -0.3%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,124.05 -0.7%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,730.05 +0.6%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,180.05 -0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 5,439.40 -1.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 887.50 5,095.45 +2.2%
Mankind Pharma Ltd. Consolidated 2023-03 1,309.68 1,739.80 -0.7%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 1,245.23 1,844.85 -0.3%

Procter & Gamble Health Ltd. FAQ's

What is Procter&Gamble Healt share price?
Can I buy Procter&Gamble Healt shares now?
What is the Dividend Yield of Procter&Gamble Healt?
What is the Market Cap of Procter&Gamble Healt?
What are the key metrics to analyse Procter&Gamble Healt?
What is the 52 Week High and Low of Procter&Gamble Healt?
What is the trend of Procter&Gamble Healt share price?